Adacolumn

DEVICE3 trials

Sponsors

Otsuka America Pharmaceutical, Adacyte Therapeutics SL

Conditions

Crohn DiseaseCrohn's DiseaseUlcerative Colitis

Phase 3

Study for the Treatment of Crohn's Disease With Adacolumn

CompletedNCT00162942

Otsuka America PharmaceuticalCrohn's Disease

Start: 2005-01-31End: 2007-12-31Updated: 2009-04-07

Unknown Phase

CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis

Adacyte Therapeutics SLUlcerative Colitis

Start: 2022-01-11End: 2024-10-31Target: 15Updated: 2024-01-17

National GMA Post-market Clinical Follow-up Study (GRACE)

RecruitingNCT05636709

Adacyte Therapeutics SLCrohn Disease, Ulcerative Colitis

Start: 2022-01-11End: 2026-06-30Target: 350Updated: 2025-01-30